A5069461704- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Substance Abuse Treatment and Outcomes
- Alcoholism and Thiamine Deficiency
- Opioid Use Disorder Treatment
- Cardiovascular Health and Risk Factors
- High Altitude and Hypoxia
- Travel-related health issues
- Aortic Disease and Treatment Approaches
- Religion, Spirituality, and Psychology
- Cardiac Valve Diseases and Treatments
- Religion, Society, and Development
- Renal and related cancers
- Retinal and Macular Surgery
- Gastrointestinal motility and disorders
- Surgical Sutures and Adhesives
- Facial Rejuvenation and Surgery Techniques
- Clinical Reasoning and Diagnostic Skills
- Sepsis Diagnosis and Treatment
- Vascular Malformations Diagnosis and Treatment
- Health Literacy and Information Accessibility
- Patient Safety and Medication Errors
- Diabetes Treatment and Management
- Business, Education, Mathematics Research
- Organ and Tissue Transplantation Research
Mayo Clinic in Arizona
2014-2025
Mayo Clinic in Florida
2025
WinnMed
2013-2025
Mayo Clinic Hospital
2025
Mayo Clinic
2014-2023
University of Indianapolis
2020
Indiana University – Purdue University Indianapolis
2020
The University of Texas Southwestern Medical Center
2014
Gentofte Hospital
1998
University of Copenhagen
1998
Diagnostic errors contribute to patient harm, though few data exist describe their prevalence or underlying causes among medical inpatients.
Abstract Background Bezlotoxumab is a monoclonal antibody infusion approved to prevent recurrence of Clostridioides difficile infection (CDI). The objective this study was explore outcomes associated with bezlotoxumab use at three academic medical centers. Methods A retrospective cohort conducted 180 patients who received from May 2018 through November 2023. primary outcome CDI within 12 weeks receipt bezlotoxumab. also sought evaluate risk factors for in Results Of the our institution, 165...
e20629 Background: Lung cancer (LC) and respiratory failure (RF) are major contributors to mortality in adults globally. Understanding long-term trends across demographic, racial, geographic, socio-economic groups is crucial addressing disparities improving outcomes. This study examines national patterns for LC RF the United States from 1999 2023, providing critical insights into changes over time identifying key age-adjusted rates (AAMRs). Methods: A descriptive analysis of data CDC WONDER...
e20520 Background: Cancer and respiratory failure (RF) are amongst leading causes of mortality in adults. This study investigates national trends age-adjusted rates (AAMRs) for cancer RF the United States from 1999 to 2023, focusing on disparities by gender, race, region, rural-urban residence inform public health strategies. Methods: descriptive analyzed data CDC WONDER database, adults aged 25 older. Mortality were identified using ICD-10 codes C00–C97 (cancer) J96 (RF). AAMRs per 100,000...
e24020 Background: Transcatheter aortic valve replacement (TAVR) is a widely adopted treatment for severe stenosis, but outcomes in cancer survivors with prior chest radiation therapy (C-XRT) remain uncertain. This study compares the clinical of TAVR between patients history C-XRT and those without exposure (control group). Methods: Patients were compared to control group evaluate key endpoints. For each endpoint, odds ratios (OR) 95% confidence intervals (CI) determined, heterogeneity was...